Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for Stress-Induced Alcohol Drinking
NCT02164422Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2014
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of guanfacine in alcohol dependence and alcohol use disorder (AUD) (3 arms), sponsored by Yale University. Primary endpoint: mL Per 15 Minutes at Day 25. Started Jun 2014; status: completed.
02
Drugs
guanfacine
03
Conditions
alcohol dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02164422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164422.